Former FDA Commissioner Scott Gottlieb on ensuring drug prices don't widen the income gap

CNBC's Healthy Returns summit discusses what is shaping the future of health care innovation with investors and executives. One of those executives is former FDA Commissioner Scott Gottlieb, who has penned an op-ed for about the new world of pricing troubles headed America's way with "cures" to certain illnesses. He joins "Squawk Box" to discuss.
Tue, May 21 20198:16 AM EDT